TY - JOUR
T1 - Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases
T2 - JACC Focus Seminar 3/4
AU - Semsarian, Christopher
AU - Gray, Belinda
AU - Haugaa, Kristina H.
AU - Lampert, Rachel
AU - Sharma, Sanjay
AU - Kovacic, Jason C.
N1 - Funding Information:
Dr Semsarian is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (1154992); and is supported by a New South Wales Health Cardiovascular Disease Senior Scientist Grant. Dr Gray is the recipient of a NHMRC Early Career Fellowship (1122330). Dr Haugaa is the recipient of grants from the Norwegian Research Council (309762, 288438, and 298736). Dr Kovacic has received research support from the National Institutes of Health (R01HL148167), New South Wales health grant RG194194, the Bourne Foundation, and Agilent; and is the recipient of an Agilent Thought Leader Award (January 2022), which includes funding for research that is unrelated to the current paper. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2022 American College of Cardiology Foundation
PY - 2022/9/27
Y1 - 2022/9/27
N2 - As explored throughout this JACC Focus Seminar series, participation in regular exercise offers significant positive benefits for cardiovascular health. However, patients with underlying inherited cardiovascular diseases, such as hypertrophic cardiomyopathy, have historically been restricted from sports participation because of the risk of sudden cardiac death. Over the last decade, new data has challenged this restrictive approach. Today, the notion of individualized, patient-centered shared decision-making is being progressively adopted to guide patients with an inherited cardiovascular disease to decide if they can undertake regular exercise, or even if they can participate in competitive sports. Here in this part 3 of a 4-part seminar series, we focus on these concepts and recent data with respect to exercise and the heart in patients with hypertrophic cardiomyopathy and other inherited cardiovascular diseases, with particular emphasis on participation in recreational and competitive sports for these individuals.
AB - As explored throughout this JACC Focus Seminar series, participation in regular exercise offers significant positive benefits for cardiovascular health. However, patients with underlying inherited cardiovascular diseases, such as hypertrophic cardiomyopathy, have historically been restricted from sports participation because of the risk of sudden cardiac death. Over the last decade, new data has challenged this restrictive approach. Today, the notion of individualized, patient-centered shared decision-making is being progressively adopted to guide patients with an inherited cardiovascular disease to decide if they can undertake regular exercise, or even if they can participate in competitive sports. Here in this part 3 of a 4-part seminar series, we focus on these concepts and recent data with respect to exercise and the heart in patients with hypertrophic cardiomyopathy and other inherited cardiovascular diseases, with particular emphasis on participation in recreational and competitive sports for these individuals.
KW - athlete's heart
KW - cardiovascular
KW - exercise
KW - hypertrophic cardiomyopathy
KW - shared decision-making
UR - http://www.scopus.com/inward/record.url?scp=85138496360&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2022.07.013
DO - 10.1016/j.jacc.2022.07.013
M3 - Review article
C2 - 36075839
AN - SCOPUS:85138496360
SN - 0735-1097
VL - 80
SP - 1268
EP - 1283
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 13
ER -
